Literature DB >> 28812097

[The best multimodal treatment for locally advanced nasopharyngeal carcinoma : An update of the MAC-NPC data].

Martina Becker-Schiebe1, Hans Christiansen2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28812097     DOI： 10.1007/s00066-017-1189-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  12 in total

1.  Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.

Authors:  Anne W M Lee; Stewart Y Tung; Roger K C Ngan; Rick Chappell; Daniel T T Chua; T X Lu; Lillian Siu; Terence Tan; L K Chan; W T Ng; T W Leung; Y T Fu; Gordon K H Au; C Zhao; Brian O'Sullivan; E H Tan; W H Lau
Journal:  Eur J Cancer       Date:  2010-11-26       Impact factor: 9.162

2.  Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma.

Authors:  Terence Tan; Wan-Teck Lim; Kam-Weng Fong; Shie-Lee Cheah; Yoke-Lim Soong; Mei-Kim Ang; Quan-Sing Ng; Daniel Tan; Whee-Sze Ong; Sze-Huey Tan; Connie Yip; Daniel Quah; Khee-Chee Soo; Joseph Wee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-01       Impact factor: 7.038

Review 3.  Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.

Authors:  Anne W M Lee; Wai Tong Ng; Lucy L K Chan; Wai Man Hung; Connie C C Chan; Henry C K Sze; Oscar S H Chan; Amy T Y Chang; Rebecca M W Yeung
Journal:  Radiother Oncol       Date:  2014-03-11       Impact factor: 6.280

4.  Nasopharyngeal carcinoma-some closing remarks.

Authors:  Joseph Tien Seng Wee; Yoke-Lim Soong; Sharon Shuxian Poh; Melvin Lee Kiang Chua
Journal:  Chin Clin Oncol       Date:  2016-04

5.  A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma.

Authors:  Y P Chen; Z X Wang; L Chen; X Liu; L L Tang; Y P Mao; W F Li; A H Lin; Y Sun; J Ma
Journal:  Ann Oncol       Date:  2014-10-29       Impact factor: 32.976

6.  Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.

Authors:  Dora L W Kwong; Jonathan S T Sham; Gordon K H Au; Daniel T T Chua; Philip W K Kwong; Ashley C K Cheng; P M Wu; Martin W M Law; Carol C H Kwok; C C Yau; K Y Wan; Raymond T T Chan; Damon D K Choy
Journal:  J Clin Oncol       Date:  2004-07-01       Impact factor: 44.544

7.  Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma.

Authors:  X Wu; P Y Huang; P J Peng; L X Lu; F Han; S X Wu; X Hou; H Y Zhao; Y Huang; W F Fang; Y Y Zhao; C Xue; Z H Hu; J Zhang; J W Zhang; Y X Ma; W H Liang; C Zhao; L Zhang
Journal:  Ann Oncol       Date:  2013-05-09       Impact factor: 32.976

8.  Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.

Authors:  Pierre Blanchard; Anne Lee; Sophie Marguet; Julie Leclercq; Wai Tong Ng; Jun Ma; Anthony T C Chan; Pei-Yu Huang; Ellen Benhamou; Guopei Zhu; Daniel T T Chua; Yong Chen; Hai-Qiang Mai; Dora L W Kwong; Shie Lee Cheah; James Moon; Yuk Tung; Kwan-Hwa Chi; George Fountzilas; Li Zhang; Edwin Pun Hui; Tai-Xiang Lu; Jean Bourhis; Jean Pierre Pignon
Journal:  Lancet Oncol       Date:  2015-05-06       Impact factor: 41.316

9.  The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials.

Authors:  Hongliang Yu; Dayong Gu; Xia He; Xianshu Gao; Xiuhua Bian
Journal:  Onco Targets Ther       Date:  2016-01-05       Impact factor: 4.147

10.  Nasopharyngeal carcinoma in adults: treatment results after long-term follow-up with special reference to adjuvant interferon-beta in undifferentiated carcinomas.

Authors:  Hendrik Andreas Wolff; Ralph M W Rödel; Bastian Gunawan; Tobias Overbeck; Markus K A Herrmann; Steffen Hennies; Andrea Hille; Hilke Vorwerk; Christoph Matthias; Clemens F Hess; Hans Christiansen
Journal:  J Cancer Res Clin Oncol       Date:  2009-07-18       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.